Infiltrating T lymphocytes in the tumor microenvironment of small cell lung cancer: a state of knowledge review
- 8 January 2022
- journal article
- review article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 148 (4) , 881-895
Abstract
Immune checkpoint inhibitors (ICIs) have brought new hope for the treatment of patients with small cell lung cancer (SCLC) over the past decades. However, the overall response rate is limited, and is lower than that in non-small cell lung cancer (NSCLC). This is in part because of the lack of pre-existing tumor-infiltrating T lymphocytes (TITLs), especially cytotoxic T cells (CTLs), in the SCLC tumor microenvironment (TME), resulting in insufficient anti-tumor immune response. To unleash the full potential of ICIs, the trafficking and infiltration of TITLs to the tumor is necessary and tightly regulated, the highly immunosuppressive tumor microenvironment blunts the infiltration and function of TITLs that reach the tumor in SCLC. Here, we review the characteristics of TITLs, the effects of various factors on T cell infiltration, and possible strategies to restore or promote T cell infiltration in the TME of SCLC.Keywords
Funding Information
- National Natural Science Foundation of China (81672972)
- Medical and Health Science Foundation of Zhe Jiang Province (2018255396)
This publication has 136 references indexed in Scilit:
- HIF-1α effects on angiogenic potential in human small cell lung carcinomaJournal of Experimental & Clinical Cancer Research, 2011
- Targeting Gastrin-Releasing Peptide Receptors on Small Cell Lung Cancer Cells with a Bispecific Molecule that Activates Polyclonal T LymphocytesClinical Cancer Research, 2006
- ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through β1 integrin-dependent activation of PI3-kinaseCell Death & Differentiation, 2006
- Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3Lung Cancer, 2004
- Complicated Mechanisms of Class II Transactivator Transcription Deficiency in Small Cell Lung Cancer and NeuroblastomaThe American Journal of Pathology, 2002
- The role of extracellular matrix in small-cell lung cancerThe Lancet Oncology, 2001
- The Biology of Chemokines and their ReceptorsAnnual Review of Immunology, 2000
- Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancerThe Journal of Pathology, 1999
- Constitutive secretion of bioactive transforming growth factor β1 by small cell lung cancer cell linesEuropean Journal of Cancer, 1994
- Interferon-mediated in vivo induction of β2-microglobulin on small-cell lung cancers and mid-gut carcinoidsClinical Immunology and Immunopathology, 1986